Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) — Cash Flow-to-Debt Ratio
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has a Cash Flow-to-Debt Ratio of -0.03x as of September 2025, meaning its operating cash flow of CN¥-17.57 Million could theoretically repay 0% of its total liabilities (CN¥567.12 Million) in one year. See 300534 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd across 15 annual periods. Also explore net asset momentum of Gansu Longshenrongfa Pharmaceutical Indu to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2011–2025)
Year-by-year debt coverage analysis for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. For market capitalisation and broader financial context, see 300534 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.01x | CN¥-6.54 Million | CN¥613.42 Million | ▼ -104.2% |
| 2024 | 0.25x | CN¥170.14 Million | CN¥674.39 Million | ▲ +63.4% |
| 2023 | 0.15x | CN¥96.53 Million | CN¥625.14 Million | ▲ +102.2% |
| 2022 | 0.08x | CN¥11.43 Million | CN¥149.66 Million | ▼ -86.4% |
| 2021 | 0.56x | CN¥51.13 Million | CN¥91.24 Million | ▲ +64.3% |
| 2020 | 0.34x | CN¥43.50 Million | CN¥127.53 Million | ▼ -13.8% |
| 2019 | 0.40x | CN¥28.21 Million | CN¥71.26 Million | ▲ +123.1% |
| 2018 | 0.18x | CN¥10.23 Million | CN¥57.68 Million | ▲ +704.9% |
| 2017 | -0.03x | CN¥-2.05 Million | CN¥70.04 Million | ▼ -113.3% |
| 2016 | 0.22x | CN¥13.14 Million | CN¥59.74 Million | ▲ +73.3% |
| 2015 | 0.13x | CN¥30.60 Million | CN¥241.17 Million | ▼ -62.5% |
| 2014 | 0.34x | CN¥39.01 Million | CN¥115.40 Million | ▲ +27.1% |
| 2013 | 0.27x | CN¥35.92 Million | CN¥135.04 Million | ▼ -8.1% |
| 2012 | 0.29x | CN¥35.62 Million | CN¥123.07 Million | ▲ +114.0% |
| 2011 | 0.14x | CN¥10.16 Million | CN¥75.15 Million | — |